Microsulis Medical Limited Release: First U.S. Patient Treated with the Accu2i Percutaneous Microwave Tissue Ablation Device (pMTA)
12/6/2010 11:26:11 AM
DENMEAD, England--(BUSINESS WIRE)--Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the first U.S. patient was treated with the company’s Accu2i percutaneous microwave tissue ablation (pMTA) system. The Accu2i pMTA system, which is now in worldwide distribution, is indicated for the coagulation of soft tissue during surgical procedures and recently received U.S. Food and Drug Administration (FDA) clearance.
comments powered by